Frontlight ResearchEarly access
Trial site
Gemeinnuetzige Gesellschaft der Franziskanerinnen zu Olpe mbH
- 3running trials
- 2closed trials
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Atrial fibrillation3 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Heart failure1 trial
- Phase
- Phase 34 trials
- Phase 41 trial
- Status
- Completed2 trials
- Active, not recruiting1 trial
- Not yet recruiting1 trial
- Recruiting1 trial
- Lead sponsor
- Janssen Research & Development, LLC2 trials
- Boehringer Ingelheim1 trial
- Ottawa Heart Institute Research Corporation1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Recruiting
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
Recruiting
Active, not recruiting
A Study of Milvexian Versus Apixaban in Participants With Atrial Fibrillation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Atrial fibrillation1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 19 Nov 2026